Discovering the machinery and mechanism of ERAD-M retrotranslocation

发现 ERAD-M 逆转录转位的机制和机制

• 批准号: 9061744
• 负责人: Sonya Elina Neal
• 金额: $ 5.8万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-05-01 至 2017-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9061744
• 关键词: 26S proteasome; Aging; Alzheimer' s Disease; Binding; Biochemical; Biochemical Genetics; Biological Assay; Biological Process; Candidate Disease Gene; Cells; Cellular Stress; Clinical; Collection; Complex; Cytosol; Defect; Degradation Pathway; Dependence; Disease; Endoplasmic Reticulum; Ensure; Enzymes; Event; Excision; Gene Proteins; Genes; Genetic; Genetic Screening; Goals; Health; Heart; Huntington Disease; Hydroxymethylglutaryl-CoA reductase; In Vitro; Isoenzymes; Knowledge; Laboratories; Libraries; Location; Maintenance; Membrane; Membrane Proteins; Methods; Modeling; Nature; Parkinson Disease; Parkinsonian Disorders; Pathway interactions; Phase; Prions; Process; Protein translocation; Proteins; Proteomics; Quality Control; Regulation; Rheumatoid Arthritis; Role; Route; Running; Sterols; Stress; Syndrome; Techniques; Testing; Ubiquitin; Ursidae Family; Validation; Variant; Work; Yeasts; base; forward genetics; gene discovery; genetic approach; in vitro Assay; in vivo; luminal membrane; member; multicatalytic endopeptidase complex; novel; novel therapeutics; physical property; protein degradation; protein folding; protein misfolding; prototype; tool

DESCRIPTION (provided by applicant): Elimination of misfolded proteins by ER-associated protein degradation (ERAD) ensures that proteins entering the secretory pathway are correctly folded and that ER stress is maintained at acceptable low levels. All variations of ERAD includes a protein translocation process termed retrotranslocation, in which ubiquitinated ERAD subsrates are selectively extracted by dedicated machinery from the ER before degradation by the cytosolic 26S proteasome. The overall goal of this project is to unravel the unknown mechanism of retrotranslocation. In the course of discovering the conserved HRD ERAD pathway, our laboratory has developed a variety of unique tools, techniques and expertise that will be brought to bear on the pressing and open question of retrotranslocation. Specifically, I will 1) perform biochemical and proteomic analyses on the prototypical ERAD substrate HMG-CoA reductase to understand the mechanism of its retrotranslocation from the ER and identify the key proteins involved in this process. Furthermore, I will 2) employ a genetic approach as an independent and complementary approach to identify retrotranslocation factors. They will include running traditional and array-based screens, combined with validation of candidate genes using direct in vivo and in vitro assays. Finally, 3) I will discern the roles of all discoveed factors in each known branch of ERAD. Taken together, these studies will reveal a key, universal and conserved process at the heart of ERAD involved in managing cell stress and a variety of clinical maladies. My studies in yeast will provide a new fundamental knowledge of the retrotranslocation process of ERAD. ERAD has been implicated in diseases such as aging, Alzheimer's disease, Huntington's disease, Parkinson's disease and in normal sterol regulation, my studies are pertinent for understanding how defects in ERAD are associated with these processes and maladies.

描述（由申请方提供）：通过ER相关蛋白降解（ERAD）消除错误折叠的蛋白质，确保进入分泌途径的蛋白质正确折叠，并将ER应激维持在可接受的低水平。ERAD的所有变体包括称为逆转位的蛋白质易位过程，其中泛素化的ERAD底物在被胞质26 S蛋白酶体降解之前通过专用机械从ER选择性地提取。这个项目的总体目标是解开未知的逆易位机制。在发现保守的HRD ERAD途径的过程中，我们的实验室已经开发了各种独特的工具，技术和专业知识，将被带到承担逆易位的紧迫和开放的问题。具体而言，我将1）对原型ERAD底物HMG-CoA还原酶进行生化和蛋白质组学分析，以了解其从ER逆转录转运的机制，并确定参与此过程的关键蛋白质。此外，我将2）采用遗传学方法作为一种独立和互补的方法来鉴定逆易位因子。它们将包括运行传统的和基于阵列的筛选，结合使用直接体内和体外测定来验证候选基因。最后，3）我将在ERAD的每个已知分支中辨别所有发现的因素的作用。总之，这些研究将揭示ERAD核心的关键，通用和保守的过程，涉及管理细胞应激和各种临床疾病。我在酵母中的研究将为ERAD的逆易位过程提供新的基础知识。ERAD与衰老、阿尔茨海默病、亨廷顿病、帕金森病等疾病以及正常的固醇调节有关，我的研究有助于了解ERAD缺陷如何与这些过程和疾病相关。